Guidelines on the use of extracorporeal photopheresis

BACKGROUND: After the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma was published in 1983 with its subsequent recognition by the FDA for its refractory forms, the technology has shown significant promise in the treatment of othe...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Eur Acad Dermatol Venereol
Main Authors: Knobler, R, Berlin, G, Calzavara-Pinton, P, Greinix, H, Jaksch, P, Laroche, L, Ludvigsson, J, Quaglino, P, Reinisch, W, Scarisbrick, J, Schwarz, T, Wolf, P, Arenberger, P, Assaf, C, Bagot, M, Barr, M, Bohbot, A, Bruckner-Tuderman, L, Dreno, B, Enk, A, French, L, Gniadecki, R, Gollnick, H, Hertl, M, Jantschitsch, C, Jung, A, Just, U, Klemke, C-D, Lippert, U, Luger, T, Papadavid, E, Pehamberger, H, Ranki, A, Stadler, R, Sterry, W, Wolf, IH, Worm, M, Zic, J, Zouboulis, CC, Hillen, U
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Guidelines on the Use of Extracorporeal Photopheresis. Publication of This Supplement was Supported by a Grant From the European Dermatology Forum
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4291097/
https://ncbi.nlm.nih.gov/pubmed/24354653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.12311
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados